International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants: Impact of air pollution on patients with AR: Current knowledge and future strategies
Descripción general
Resumen del artículo
Air pollution worsens allergic rhinitis symptoms through complex interactions involving oxidative stress and inflammatory pathways. Managing AR aggravated by air pollution requires a multi-pronged approach, including standard AR treatment, reducing exposure to pollutants, and potentially using antioxidants, though more research is needed on specific therapies for this combined condition.
Explícamelo como si tuviera cinco años
Scientists found that when the air is dirty with smoke and dust, it makes your nose allergies even worse. To feel better, you can take your medicine and try to avoid the dirty air.
Posibles conflictos de intereses
Some authors have disclosed relationships with pharmaceutical companies involved in allergy treatment, including Lyra, Sanofi, Actos, Optinose, Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Takeda, Teva, Uriach, Kyomed, BI, ALK, Stallergens, GSK, Hal, AZ, MSD, Danone, Novartis, Chiesi, AstraZeneca, Aché, FDA Allergenic, Boehringer Ingelheim, MEDA, Allergy Therapeutics, Chattem, US EPA, and CDC.
Limitaciones identificadas
Explicación de la calificación
This review provides a comprehensive overview of the impact of air pollution on allergic rhinitis, summarizing current knowledge and identifying key mechanisms like oxidative stress. While limited by the nature of a review and potential conflicts of interest, it highlights important areas for future research and offers practical recommendations for patients and clinicians.
Conviene saber
Este es el análisis de Starter. Paperzilla Pro verifica cada cita, investiga los antecedentes de los autores y las fuentes de financiación, y utiliza razonamiento avanzado con IA para ofrecer información más exhaustiva.
Explorar Pro →